Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med. 2002;32:35–46.
Article
PubMed
Google Scholar
Pham KH, Ramawamy MR, Hawkins RA. Advances in positron emission tomography imaging in the GI tract. Gastrointest Endosc. 2002;55(Suppl 7):553–63.
Google Scholar
Van Hertum RI, Fawvaz RA. The role of nuclear medicine in the evaluation of pancreatic disease. Surg Clin North Am. 2001;8:345–58.
Article
Google Scholar
Sone Y, Sobajima A, Kawachi T, Kohara S, Kato K, Naganawa S. Ability of 18-fluorodeoxyglucose positron emission tomography/CT to detect incidental cancer. Bt. J Radiol. 2014;87:20140030.
Article
CAS
Google Scholar
Minamimoto R, Senda M, Jinnouchi S, Terauchi T, Yoshida T, Murano T, Fukuda H, linuma T, Uno K, Nishizawa S, Tsukamoto E, Iwata H, Inoue T, Oguchi K, Nakashima R, Inoue T. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009), nationwide survey. Ann Nucl Med. 2013;27:46–57.
Article
PubMed
Google Scholar
Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ. 18-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma. Head Neck. 2010;32:319–25.
PubMed
Google Scholar
Adams HL, Janunoo SS. Clinical significance of incidental findings on staging positron emission tomography for oesophago-gastric malignancies. Ann R Coll Surg Engl. 2014;96:207–10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sato K, Ozaki K, Fujiwara S, Oh I, Matsuyama T, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K. Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma. Int J Hematol. 2010;92:647–50.
Article
PubMed
Google Scholar
Chopra A, Ford A, de Noronha R, Matthews S. Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer. Br J Radiol. 2012;85:e229–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752.757.
Google Scholar
Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Zet K, Fischer D. PET/CT detection of unexpected gastrointestinal foci of 18-FDG uptake: incidence, localization patterns and clinical significance. J Nucl Med. 2005;46:758–62.
PubMed
Google Scholar
Vella-Bocaud J, Papathanassiou D, Bouche O, Prevost A, Lestra T, Dury S, Vallerand H, Perotin JM, Launois C, Boissiere L, Brasseur M, Lebargy F, Deslee G. Incidental gastrointestinal 18F-Fluorodeoxyglucose uptake associated with lung cancer. BMC Pulm Med. 2015;15:152.
Article
Google Scholar
Andia GS, Soriano AP, Ortega Candil A, Cabrera Martin MN, Gonzalez Roiz JJ, Ortiz Zapata JJ, Cardona Arbonies J, Lapena Gutierrez L, Carreras Delgado JL. Clinical relevance of incidental finding of focal uptakes in the colon during 18-FDG PET/CT studies in oncologic patients without known colorectal carcinoma and evaluation of the impact on management. Rev Esp Med Nucl. 2012;31:15–21.
Google Scholar
Goldin E, Mahamid M, Koslowsky B, Shteingart S, Dubner Y, Lalazar G, Wengrover D. Unexpected FDG-PET uptake in the gastrointestinal tract: endoscopic and histopathological correlations. World J Gastroenterol. 2014;20:4377–81.
Article
PubMed
PubMed Central
Google Scholar
Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Color Dis. 2011;13:e374–8.
Article
CAS
Google Scholar
Tatidi R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake : correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783–7.
Article
Google Scholar
Treglia G, Calcagni ML, Rufini V, Leccisotti L, Meduri GM, Spitilli MG, Dambra DP, De Gaetano AM, Giordano A. Clinical significance of incidental focal colorectal 18F-fuorodeoxyglucose uptake: our experience and a review of the literature. Color Dis. 2011;14:174–80.
Article
Google Scholar
Kunawudhi A, Wong AK, Alkasab TK, Mahmood U. Accuracy of FDG-PET/CT for detection of incidental premalignant and malignant colonic lesions-correlations with colonoscopic and histopathologic findings. Asian Pac J Cancer Prev. 2016;17:4143–7.
PubMed
Google Scholar
Sperti C, Pasquali C, Bissoli S, Chierichetti F, Liessi G, Pedrazzoli S. Tumor relapse after pancreatic cancer resection is detected earlier by 18-FDG PET than by CT. J Gastrointest Surg. 2010;14:131–40.
Article
PubMed
Google Scholar
Reid-Lombardo KM, Mathis KL, Wood CM, Harmsen WS, Sarr MG. Frequency of extrapancreatic neoplasms in intraductal papillary mucinous neoplasms of the pancreas: implications for management. Ann Surg. 2010;251:64–9.
Article
PubMed
Google Scholar
Larghi A, Panic N, Capurso G, Leoncini E, Arzani D, Salvia R, Del Chiaro M, Frulloni L, Arcidiacono PG, Zerbi A, Manta R, Fabbri C, Ventrucci M, Tarantino I, Piciucchi M, Carnuccio A, Boggi U, Costamagna G, Delle Fave G, Pezzili R, Bassi C, Bulajic M, Ricciardi W, Boccia S. Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol. 2013;24:1907–11.
Article
CAS
PubMed
Google Scholar
Kawakubo K, Tada M, Isayama H, Sasahira N, Nakai Y, Yamamoto K, Kogure H, Sasaki T, Hirano K, Ijichi H, Tateishi K, Yoshida H, Koike K. Incidence of extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60:1249–53.
Article
PubMed
Google Scholar
Malleo G, Marchegiani G, Borin A, Capelli P, Accordini F, Butturini G, Pederzoli P, Bassi C, Salvia R. Observational study of the incidence of pancreatic and extraèpancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm. Ann Surg. 2015;281:984–90.
Article
Google Scholar